03.12.15
Burlington, Mass.-based Infraredx Inc., a cardiovascular imaging technology company, is debuting its Advanced TVC Imaging System and the Muller NIRS-IVUS Catheter Extended Bandwidth IVUS technology at the American College of Cardiology’s 2015 Annual Scientific Meeting. The conference will be held from March 14-16 in San Diego, Calif.
The Advanced TVC Imaging System is a U.S. Food and Drug Administration-cleared technology designed to rapidly, specifically and reliably identify lipid-core plaques (LCPs), which are known to complicate stenting procedures and suspected to cause most heart attacks.
The Advanced TVC Imaging System integrates near-infrared spectroscopy (NIRS) with intravascular ultrasound (IVUS), which helps physicians determine procedural and treatment strategies based on information on vessel structure and plaque composition. This new platform is designed to evolve with coronary care and incorporates advanced computing technology, the latest high-definition monitors, an intuitive, user-friendly interface and near-infrared laser optics for in vivo chemical analysis. The system also includes Infraredx’s proprietary Extended Bandwidth IVUS technology, which represents the next generation in IVUS imaging. Extended Bandwidth ultrasound technology harmonizes multiple signal frequencies to produce a sharp image of the complete vessel that allows for easy identification of the lumen, plaque and vessel structure, the company reports.
“Over the past 25 years, there have been few technological innovations in intravascular imaging systems that compare with those introduced in the TVC Imaging Systems,” said CEO Don Southard. “Understanding vessel structure and plaque composition is critically important for interventional cardiologists. The Advanced TVC Imaging System will assist physicians to achieve their goal of optimizing PCI procedures. At the ACC Annual Meeting, we look forward to unveiling our latest advancements, which we believe will be of great value for the care of coronary patients, and move closer to the goal of preventing the initial onset of heart attacks.”
The Advanced TVC Imaging System is a U.S. Food and Drug Administration-cleared technology designed to rapidly, specifically and reliably identify lipid-core plaques (LCPs), which are known to complicate stenting procedures and suspected to cause most heart attacks.
The Advanced TVC Imaging System integrates near-infrared spectroscopy (NIRS) with intravascular ultrasound (IVUS), which helps physicians determine procedural and treatment strategies based on information on vessel structure and plaque composition. This new platform is designed to evolve with coronary care and incorporates advanced computing technology, the latest high-definition monitors, an intuitive, user-friendly interface and near-infrared laser optics for in vivo chemical analysis. The system also includes Infraredx’s proprietary Extended Bandwidth IVUS technology, which represents the next generation in IVUS imaging. Extended Bandwidth ultrasound technology harmonizes multiple signal frequencies to produce a sharp image of the complete vessel that allows for easy identification of the lumen, plaque and vessel structure, the company reports.
“Over the past 25 years, there have been few technological innovations in intravascular imaging systems that compare with those introduced in the TVC Imaging Systems,” said CEO Don Southard. “Understanding vessel structure and plaque composition is critically important for interventional cardiologists. The Advanced TVC Imaging System will assist physicians to achieve their goal of optimizing PCI procedures. At the ACC Annual Meeting, we look forward to unveiling our latest advancements, which we believe will be of great value for the care of coronary patients, and move closer to the goal of preventing the initial onset of heart attacks.”